Clinical trial

Phase I/II, Open-Label Trial of Three Monoclonal Antibodies

NCT00219986

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2003-10-01

PhasePHASE1 / PHASE2

Study timeline

Study start (unknown)2003-10-01Date precision: month

Registry last updated2007-07-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIV Infectionsunresolved

Interventions

Potent HAART during acute or early HIV-1 infectionDRUG

Sponsors & collaborators

Rockefeller Universitylead sponsor

Mapped research locations

New YorkNew York, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00219986 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.